Aclys Bio
Aclys Bio is a Lebanon-based company that specializes in building precision antibodies for the treatment of cancer patients. Their approach involves using molecular profiling data from tens of thousands of cancer patients to design antibodies that offer higher efficacy, smaller trial sizes, lower trial costs, faster approval, and a higher likelihood of FDA approval.
By employing a combination of computational methods, rational design, and their proprietary mammalian cell-based discovery and optimization platform, Aclys Bio is able to develop antibodies of the highest quality on an accelerated timeline. They also collaborate with leading drug developers to maximize the impact of their pipeline and bring new-to-world therapies to market.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
